Fluoxetine no longer a clear winner in adolescent depression

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.585, 2009-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluoxetine/CBT a tad better in adolescent depression

Inpharma, Vol. 1, Iss. 1452, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Fluoxetine – do the benefits outweigh the risks in adolescent major depression?

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 147-150

Informa Healthcare

Access to resources Recommend Favorite

Efalizumab a CLEAR winner for psoriasis

Inpharma, Vol. 1, Iss. 1479, 2005-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Tazarotene the clear winner for acne vulgaris

Inpharma, Vol. 1, Iss. 1427, 2004-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Telaprevir vs boceprevir: no clear winner

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 667, 2012-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite